Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam versus carbamazepine monotherapy in children with new-onset partial epilepsy
IRCT20170216032603N2Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in epilepsy comparing Levetiracetam monotherapy with Carbamazepine monotherapy (2 arms). Primary endpoints: Seizure frequency and Medication side effects. Started Feb 2020; status: completed.
02
Drugs
levetiracetamcarbamazepine
03
Conditions
epilepsy
Beyond the preview
Go deeper on IRCT20170216032603N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170216032603N2.